- Research
- Open access
- Published:
Does intramedullary nail have advantages over dynamic hip screw for the treatment of AO/OTA31A1-A3? A meta-analysis
BMC Musculoskeletal Disorders volume 24, Article number: 588 (2023)
Abstract
Background
Hip fractures are still unsolved problems nowadays. We evaluated the functional outcomes and complications in the treatment of hip fractures (AO/OTA31A1-A3) to find potential difference and risk between intramedullary nail (IMN) and dynamic hip screw (DHS).
Method
We searched PubMed, Embase, Cochrane library up to 19 June 2023 and retrieved any studies comparing IMN and DHS in treatment of Hip fractures. The main outcomes and complications were extracted from the included studies. The fixed-effect model was selected to pool the data for homogeneous studies (I2 < 50%). Otherwise, the random effects model was selected (heterogeneity, I2 > 50%). The analysis of sensitivity and subgroup was performed to explore the homogeneous studies among studies. The p-value of less than 0.05 was considered statistically significant.
Results
30 RCT studies were included in this meta-analysis. There were significant difference of in the items of blood loss, screening time, femoral neck shortening, non-union, and femoral fractures (p < 0.05). Significant difference was found in the parameter of open reduction of fracture after sensitive analysis (p < 0.05). No significant difference was found in the parameter of Mobility Score at the last follow-up after sensitive analysis (p ≥ 0.05). There was no significant difference in the parameters of open reduction of fracture, required blood transfusion, mean surgical time, hospital stays, time to healing, mean Harris Hip Score, infection, cut out, poor reduction, breakage of implant, failure of fixation, reoperation, and systemic complications of chest infection, decubital ulcer, urinary tract infection and persistent pain in the hip (p ≥ 0.05).
Conclusions
Our meta-analysis revealed that hip fractures treated with IMN have merits with lower rate of blood loss, femoral neck shortening and non-union; shortcoming of increased risk of femoral fractures. It is suggested that special attention should be paid to the risk of femoral fracture when intramedullary nail was inserted in the intraoperative.
Background
Hip fractures are becoming increasingly common as population ages. The incidence of hip fractures is expected to reach 2.6 million by 2025 and 4.5 million by 2050 [1]. These fractures cause significant morbidity and increased mortality [2], 12–17% of patients with a hip fracture died within the first year, especially those elderly with limited activity [3]. Hip fractures include femoral neck fracture and intertrochanteric facture, and the most common fracture classification was the AO system. The choice of surgical treatment is the best strategy for the hip fractures, which has advantage of early rehabilitation and functional recovery, and reduces the risk of postoperative complications [4]. Published papers supported that the indication of dynamic hip screw (DHS) was applied for the treatment of stable fractures, basicervical fractures, and trans-cervical fractures, while intramedullary nail (IMN) was used for the treatment of stable fractures, unstable fractures, per trochanteric, reduced lateral wall thickness, reverse obliquity unstable type fractures [5,6,7].
The biomechanical superiority of IMN was that the offset was small for the reason of the femoral shaft axis nearer to the center of rotation of the hip (Fig. 1), resulting in a shorter lever arm and lower bending moment on the device [8, 9]. The characteristics of sliding and compressing of IMN can promote the healing of the fracture end [10]. The intrinsic mechanical solidity and load distribution allows nails to support most of the forces acting on the hip during gait (axial weight bearing and bending moments) avoiding stress on the fracture site [11]. In addition, a telescoping displacement of the proximal fragment was prevented by the main nail when the failure of initial stability occurred [8, 12]. On the other hand, DHS implies a relative instability in this system, not only axially but also transversally and in rotation. This potential instability could adversely affect the functional outcome, pain and healing for the hip fractures [13]. Theoretically, the fixation of IMN predicts higher healing and less complication for hip fractures. However, the inconsistent results were reported for hip fractures including functional outcome, blood loss, surgical time, complications, reoperations and so on [14,15,16,17]. The 2023 meta-analysis by Zhang et al. [18] revealed that PFNA exhibited a beneficial role in Harris Scores, operation time, blood loss, hospital stay, healing time, cut-out, reoperation, union problems, and infection; however, DHS was superior to PFNA in hidden blood loss, postoperation drainage, total blood loss, and femoral shaft fracture. Another 2022 meta-analysis by Wessels et al. [19] reported that no significant difference was found in the complication of nonunion, infection, and mortality when (AO/OTA) 31A1-A3 fractures treated with either DHS or IMN. A 2022 meta-analysis by Xu et al. reported that PFN had shorter operative time and led to less intraoperative blood loss, no difference was seen between PFN and DHS for non-union, risk of implant failure and revision surgery [20]. Given these controversial results, we remained skeptical of the relevant conclusions of these studies. We think there are many common features for the intramedullary nailing of PFNA, PFN, and GN for the treatment of hip fractures. The major difference between IMN and DHS was the offset in the device design (Fig. 1). In present meta-analysis, we considered the IMN devices including PFNA, PFN, INTERTAN nail, and GN as the same type of internal fixation device for hip fractures. The aim of present study was to systemically assess the relative parameters difference in the process of intra-operation, post-operation and complications between two groups of IMN versus DHS in treating hip fractures.
Materials and methods
Search strategy
In this study, we defined hip fractures as AO/OTA31A1-A3 to generalize all fracture types of the proximal femur. We searched the electronic databases of PubMed, Cochrane, and Embase on 19 June 2023 for all published literature. The following search terms were identified: ((Intramedullary Fracture Fixation) OR (Intramedullary Nailing)) AND ((Dynamic hip screw) OR (Sliding hip screw)) AND ((Hip Fractures) OR (Trochanteric Fractures) OR (Femoral neck fracture)). In addition, we conducted a hand search of reference lists from the eligible studies to prevent any omissions.
Inclusion and exclusion criteria
The inclusion criteria were identified as follow: (1) randomized controlled trial (RCT) studies; (2) Hip fractures (AO/OTA: A1-A3); (3) the intervention included dynamic hip screw (DHS) OR sliding hip screw (SHS) and comparison included intramedullary nailing (gamma nails, proximal femoral nail (PFN), proximal femoral nail antirotation (PFNA) and Intertan nail);(4) full text paper can be retrieved; (5) follow-up was more than 4 months. Studies would be excluded for the reasons: (1) Non-RCT studies for IMN and DHS; (2) included the non-traumatic fractures, such as pathologic fractures; (3) not original articles, including biomechanical or cadaveric studies, technical notes, letters to the editor, conference abstracts, expert opinions, review articles, meta-analyses, and case reports; (4) not report results that would allow us to obtain or calculate comparative data; and (5) non-English language.
Study selection
All studies were independently reviewed by two reviewers according to the inclusion and exclusion criteria. The full texts of all the relevant studies were obtained and reviewed. Any disagreements were resolved by consensus with another senior reviewer.
Data extraction
Data extraction was carried out critically and independently by two researchers, while a third researcher resolved any disputes. The following data was extracted: the first author’s name, publication year, research country, study design, interventions, sample size, age, gender, type of fracture, follow-up time.
Outcomes
The included studies were identified at least one of the following outcomes: (a) intra-operative difference (open reduction of fracture, blood loose (ml), required blood transfusion, screening time (min), mean surgical time (min)); (b) post-operative difference (hospital stay (days), time to healing (days), femoral neck shortening (mm), mean Harris hip score and mobility score); (c) total orthopedic complications; (d) subgroup analysis of orthopedic complications (infection, cut out, poor reduction, breakage of implant, non-union, femoral fracture, failure of fixation and reoperation); (e) systemic complications (chest infection, decubitus ulcer, urinary tract infection and persistent pain in the hip).
Risk of bias assessment
Two authors independently assessed the risk of bias of all studies included in the meta-analysis. The Cochrane risk of bias (ROB) assessment tool was applied for the risk of bias assessment of RCT studies [21]. The included items were listed as follows, random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and investigators (performance bias), blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective reporting (reporting bias), and other bias. Each study was classified in each domain as low, unclear, or high risk of bias. Disagreement was resolved by consensus amongst group discussion.
Statistical analysis
Statistical analysis was performed by the software of RevMan 5.4 (The Cochrane Collaboration, 2020). We used standardized mean differences (SMD) and 95% confidence intervals (CI) to express continuous data, and the pooled odds ratio (OR) with a 95% confidence interval (CI) to calculate for dichotomous outcomes. Heterogeneity was assessed with the I2. If there was significant heterogeneity (I2 > 50%), we selected a random effects model to pool the data. On the contrary (I2 < 50%), the fixed-effect model was selected. A method of sensitivity analysis and subgroup analysis was performed to explore the source of heterogeneity [22]. Publication bias was investigated by funnel plot and an asymmetric plot suggested possible publication bias [23]. All p-values were two-sided and a p-value of less than 0.05 was considered statistically significant.
Results
Literature characteristics
The initial search of the databases yielded 456 studies from Pubmed, Embase and Cochrane; 18 additional studies were added from the reference sources. 318 studies were removed for the reason of duplicates and unrelated topic. 84 studies were excluded for the reasons of review, meta-analysis, books and documents. Then, 31 of records were excluded with the reasons of non-comparison trial or surgical techniques, non-comparison of DHS and IMN, and non-English language. 44 remaining full-text articles were then screened, 5 studies were excluded with the reason of no valid extractable data, and then 9 articles were excluded with the reason of Non RCT studies. Finally, 30 studies were eligible for the meta-analysis. The PRISMA flow diagram and checklist for this search is shown in Fig. 2. Of the included 30 studies, a total of 3293 subjects underwent fixation with IMN and 3357 with DHS. The related characteristic of the studies was summarized in Table 1. The follow-up time for the involved studies was more than 4 months.
Quality assessment
The included RCT studies were assessed for the risk of bias according to Cochrane Handbook for Systematic reviews and interventions [21]. For the included 30 RCT studies, 8 studies were assessed for high risk for random sequence generation. Low bias was found in terms of incomplete outcome data and selective reporting. The risk bias of each item was summarized in the Fig. 3.
Outcomes
Intraoperative details
The operative difference between the groups of IMN and DHS was presented in the Fig. 4. Significant difference was found in the parameters of blood loss (MD=-124.43ml, 95%CI [-169.76, -79.09], p < 0.0001), and screening time (MD = 0.530.43 min, 95%CI [0.28, 0.78], p < 0.0001). There was no significant difference in the items of open reduction of fracture (OR = 0.04, 95%CI [0.00, 1.60], p = 0.09), required blood transfusion (OR = 0.67, 95%CI [0.43, 1.02], p = 0.06) and mean surgical time (OR=-5.18, 95%CI [-11.31, 0.96]). There was great heterogeneity for the parameter of open reduction of fracture (p = 0.0002, I2 = 82%). So, the sensitivity analysis was conducted by excluding Saudan et al. [24], then the remaining studies were homogeneous (p = 0.16, I2 = 49%). Significant difference was found between two groups in the parameter of open reduction of fracture (OR = 0.01, 95%CI [0.00, 0.14], p = 0.0009). For other parameters of blood loss, required blood transfusion, screening time and mean surgical time, the heterogeneity was inevitable between the studies after sensitivity analysis, and the random-effect model was applied to pool the data for statistical analysis. The results of operative details revealed that there were advantages of IMN in the items of blood loss and screening time; while shortcoming of open reduction of fracture in comparison with DHS (p < 0.05). No significant difference was found in the items of required blood transfusion and mean surgical time between IMN and DHS (p ≥ 0.05).
Postoperative details
The postoperative difference between the groups of IMN and DHS was presented in the Fig. 5. There was no significant difference in the items of hospital stays (MD=-0.16 days, 95%CI [-0.63, 0.31], p = 0.49), and time to healing (MD=-5.15 days, 95%CI [-29.32, 19.03], p = 0.68), and mean Harris score (MD=-1.02, 95%CI [-12.12, 10.08], p = 0.86). Significant difference was found in the parameters of femoral neck shortening (MD=-0.65, 95%CI [-0.96, -0.34], p < 0.0001), and mobility score at last follow-up (MD = 0.29, 95%CI [0.01, 0.57], p = 0.04). There was heterogeneity for the parameter of mobility score at last follow-up (p = 0.02, I2 = 66%). So, the sensitivity analysis was conducted by excluding the study of Xu et al. [25], and then the remaining studies were homogeneous (p = 0.22, I2 = 31%). No significant difference was found in the parameters of mobility score at last follow-up (95%CI [-0.06, 0.38], p = 0.15). For other parameters of femoral neck shortening, time to healing, and mean Harris score, the heterogeneity was inevitable between the studies after sensitivity analysis, and the random-effect model was applied to pool the data for statistical analysis. The results of post-operative details showed that there were advantages of IMN in the items of preventing femoral neck shortening (p < 0.05). No significant difference was found in the items of hospital stays, time to healing, mean Harris score and mobility score at last follow-up between IMN and DHS (p ≥ 0.05).
Complications
The orthopaedic complications between the groups of IMN and DHS were shown in the Fig. 6. The pooled risk ratio showed no significant difference in the items of total orthopaedic complications (OR = 1.36, 95%CI [0.94, 1.97], p = 0.11). Heterogeneity was found for the pooled 19 studies (p = 0.0002, I2 = 62%). The subgroup analysis for orthopaedic complications was used to further explore the source of heterogeneity (Figs. 7 and 8). No heterogeneity was found in the parameters of infection, cut out, poor reduction, breakage of implant, nonunion, femoral fracture, failure of fixation, and reoperation rate (p ≥ 0.05, I2 < 50%), and the fixed-effect model was used to merge the data. Significant difference between two groups was found in the parameters of non-union (OR = 0.49, 95%CI [0.30, 0.80], p = 0.004), and femoral fracture (OR = 4.34, 95%CI [2.49, 7.57], p < 0.0001). There was no significant difference in the items of infection, poor reduction, breakage of implant, failure of fixation, and reoperation (p ≥ 0.05). The pooled data of each complication rate was presented in Table 2.
Systemic complications
The difference of systemic complications between two groups was presented in the Fig. 9. There was no significant difference in the items of chest infection (OR = 0.89, 95%CI [0.51, 1.53], p = 0.67), decubitus ulcer (OR = 0.89, 95%CI [0.51, 1.56], p = 0.68), urinary tract infection (OR = 0.97, 95%CI [0.68, 1.36], p = 0.84), and persistent pain in the hip (OR = 0.93, 95%CI [0.78, 1.10], p = 0.49). No heterogeneity was found between the studies (p ≥ 0.05, I2 < 50%), and the fixed-effect model was applied to pool the data.
Discussions
Hip fractures are becoming a social concern problem with aging. These fractures bring a huge economic burden on healthcare care system because of extended hospital stays, co-morbidity and mortality [2, 26]. The goal of internal fixation for hip fractures was to achieve timely healing, early mobility, optimal functional outcome and less complication. The protocol of surgical treatment is becoming the priority choice for hip fractures on account of the advantages of early rehabilitation and activity. The IMN and the DHS are both recommended surgical procedures for intertrochanteric fractures. Treatment decisions are often guided by the surgeon’s own preference and the stability of the fracture. Nevertheless, there are conflicting findings concerning outcomes and postoperative results in the literature [26,27,28]. For the femoral neck fracture in elderly patients with a displaced fracture in coxa vara, arthroplasty will be preferred, whereas for non-displaced or coxa-valga fractures, as well as in younger patients, osteosynthesis will be performed [29]. In present study, we conducted a comparative analysis to explore the difference in the process of intra-operation, post-operation and total complications between two groups of IMN versus DHS.
Our meta-analysis revealed that significant difference between IMN and DHS was found in terms of open reduction of fracture, blood loss, screening time, femoral neck shortening and the complications of non-union and femoral fracture. No significant difference was found in other parameters of required blood transfusion, mean surgical time, hospital stays, time to healing, mean Harris Hip Score, Mobility Score, infection, cut out, poor reduction, breakage of implant, failure of fixation, and reoperation, and systemic complications of chest infection, decubital ulcer, urinary tract infection and persistent pain in the hip. The results were different from the meta-analysis from Zhang (2023) [18] and Wessels (2022) [19] for the reasons of RCT and Non-RCT studies included for their studies to pool the data. In present study, it was easy to understand that open reduction of fracture, less blood loss in operation, and need more screening time for the group of IMN. The operation of IMN required surgeons to use minimally invasive technique, then reducing open reduction of fracture, blood loss in operation and needing more fluoroscopy time in the process of intra-operation. Our meta-analysis showed that mean blood loss of IMN group was about 124.43ml (95% CI: -169.76, -79.09) less than that in DHS group. A meta-analysis based on 5 randomized controlled trials (RCTs) also proved that less blood loss (p < 0.0001) was found in the PFN group in comparison with the DHS group [30]. Mean femoral neck shortening in IMN group was 0.65 mm (95% CI: -0.96, -0.34) less than that DHS group. The explanation was that the advantage of IMN design was to produce the secondary stability when the failure of initial stability occurred [8, 12]. However, only 2 studies of 30 included papers gave an introduction of the data of femoral neck shortening, and the heterogeneity was presented after the pooled data for the 2 studies. The accuracy of the results need more randomized control studies to confirm. No difference was found in the functional outcome of mean Harris scores and the mobility scores between two groups. It was revealed that the function of hip was similar when hip fracture treated either IMN or DHS during more than 4 months follow-up. Matre et al. [31] and Parker et al. [32] also found no differences in functional outcomes using Parker Mobility Score and EQ-5D. However, the accuracy of the results need more randomized control studies to confirm for the reason of heterogeneity. The rate of non-union for IMN group (27/1571) was less common than that for DHS group 48/1560) with the OR = 0.49 (95% CI: 0.30, 0.80). The higher union rate for IMN group may be attributed to the biomechanical advantage (smaller offset) and secondary stability design for IMN [8, 9, 12]. However, the rate of femoral fracture for IMN group (61/2077) was more common than that of DHS groups (11/2086) with the OR = 4.34 (95% CI: 2.49, 7.57). Femoral fracture may be related to the insertion of main nail [33,34,35,36], the process of distal locking [34, 37], and during reaming [38]. The complication of “iatrogenic fracture” in intra-operation should be stressed in the treatment of hip fractures using IMN. It is suggested that special attention should be paid to the risk of femoral fracture when intramedullary nail was inserted in the intraoperative.
Our meta-analysis showed no significant difference was found between two groups in the complications of infection, cut out, poor reduction, breakage of implant, failure of fixation, and reoperation. In current studies, 17 RCT studies were pooled to analyze the complication of infection. 38 cases (1.8%) in the IMN groups and 55 cases (2.57%) in the DHS group developed infection, no difference was found between two groups (p > 0.05). Poor bone quality, loss of reduction, excessive collapse, and cut out are frequent causes for failure of fixation in treatment of these fractures [8, 15]. In present study, 12 included studies reported the rate of cut out between two groups. The complication rate of cut out for IMN group was 2.51% (51/2029) similar to that for DHS groups (2.22%, 46/2068). Many authors have reported high reoperation rates with DHS for hip fractures, and the most common causes of failure are screw cut-out and fracture collapse [8, 12, 39]. In present study, no significant difference was found in term of cut out between two groups (p = 0.87). Our meta-analysis also proved no significant difference in the aspect of failure of fixation and reoperation. Yu et al. [40] reported that the reoperation rate of 6.4% for PFNA and of 13.4% for DHS groups. After the pooled data for 11 included studies, the reoperation rates were 5.32% (90/1691) for IMN group and 4.50% (76/1692) for DHS groups. Systemic complications were also analyzed using meta-analysis. No significant difference was found in terms of chest infection, decubitus ulcers, urinary tract infection and persistent pain in the hip. The most complications were the urinary tract infection (13.7% for IMN group and 14.2% for DHS group), then persistent pain in the hip (11.9% for IMN group and 12.9% for DHS group) after the data pooled for included studies (Table 2). It was indicated that the systemic complications of urinary tract infection and persistent pain (over 10%) should be stressed when hip fracture after operation.
Compared with previous meta-analysis [18,19,20], the merit was that only 30 RCT studies rather than RCT and non-RCT were included for meta-analysis, and the main outcomes in intraoperative and postoperative details were investigated. The limitations were listed as follows. First, the quality of this meta-analysis was limited by the quality of available literatures. Second, the difference in the implant design was applied across the studies. In present studies, we considered the IMN devices including PFNA, PFN, INTERTAN nail, and GN as the same type of internal fixation device for hip fractures. However, the Cochrane review on IMNs demonstrated no difference in the complications [41]. Third, some studies included were adjudged to have a moderate or higher overall risk of bias, largely due to the lack of study protocols, which increases the risk of reporting and measurement biases.
Conclusions
Based on the results, our meta-analysis revealed that hip fractures treated with IMN have advantages of blood loss, prevention of femoral neck shortening, and the rate of non-union, with shortcoming of open reduction, screening time and femoral fractures. As more and more surgeons are choosing intramedullary fixation for the treatment of hip fracture, we recommend special attention should be paid to the risk of femoral fracture when IMN was inserted.
Data Availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Abbreviations
- DHS:
-
Dynamic hip screw
- IMN:
-
Intramedullary nail
- Targon PF:
-
Targon Proximal Femoral Nail
- GN:
-
Gamma Nail
- PFN:
-
Proximal Femoral Nail
- PFNA:
-
Proximal Femoral Nail with Anti-rotation
- RCT:
-
Randomized Controlled Trials
- SMD:
-
Standardized mean differences
- 95%CI:
-
95% confidence intervals
- OR:
-
Odds ratio
References
Shehata MSA, Aboelnas MM, Abdulkarim AN, Abdallah AR, Ahmed H, Holton J, et al. Sliding hip screws versus cancellous screws for femoral neck fractures: a systematic review and meta-analysis. Eur J Orthop Surg Traumatol. 2019;29(7):1383–93.
Veronese N, Maggi S. Epidemiology and social costs of hip fracture. Injury. 2018;49(8):1458–60.
LeBlanc KE, Muncie HL Jr, LeBlanc LL. Hip fracture: diagnosis, treatment, and secondary prevention. Am Fam Physician. 2014;89(12):945–51.
Kenzora JE, McCarthy RE, Lowell JD, Sledge CB. Hip fracture mortality. Relation to age, treatment, preoperative illness, time of surgery, and complications. Clin Orthop Relat Res 1984(186):45–56.
Pajarinen J, Lindahl J, Savolainen V, Michelsson O, Hirvensalo E. Femoral shaft medialisation and neck-shaft angle in unstable pertrochanteric femoral fractures. Int Orthop. 2004;28(6):347–53.
Lorich DG, Geller DS, Nielson JH. Osteoporotic pertrochanteric hip fractures: management and current controversies. Instr Course Lect. 2004;53:441–54.
Marsh JL, Slongo TF, Agel J, Broderick JS, Creevey W, DeCoster TA, et al. Fracture and dislocation classification compendium – 2007: Orthopaedic Trauma Association classification, database and outcomes committee. J Orthop Trauma. 2007;21(10 Suppl):1–133.
Aune AK, Ekeland A, Odegaard B, Grøgaard B, Alho A. Gamma nail vs compression screw for trochanteric femoral fractures. 15 reoperations in a prospective, randomized study of 378 patients. Acta Orthop Scand. 1994;65(2):127–30.
Madsen JE, Naess L, Aune AK, Alho A, Ekeland A, Strømsøe K. Dynamic hip screw with trochanteric stabilizing plate in the treatment of unstable proximal femoral fractures: a comparative study with the Gamma nail and compression hip screw. J Orthop Trauma. 1998;12(4):241–8.
Haynes RC, Pöll RG, Miles AW, Weston RB. An experimental study of the failure modes of the Gamma Locking nail and AO Dynamic Hip Screw under static loading: a cadaveric study. Med Eng Phys. 1997;19(5):446–53.
Bellabarba C, Herscovici D Jr, Ricci WM. Percutaneous treatment of peritrochanteric fractures using the Gamma nail. Clin Orthop Relat Res 2000(375):30–42.
Jiang SD, Jiang LS, Zhao CQ, Dai LY. No advantages of Gamma nail over sliding hip screw in the management of peritrochanteric hip fractures: a meta-analysis of randomized controlled trials. Disabil Rehabil. 2008;30(7):493–7.
Kaufer H. Mechanics of the treatment of hip injuries. Clin Orthop Relat Res 1980(146):53–61.
Adeel K, Nadeem RD, Akhtar M, Sah RK, Mohy-Ud-Din I. Comparison of proximal femoral nail (PFN) and dynamic hip screw (DHS) for the treatment of AO type A2 and A3 pertrochanteric fractures of femur. J Pak Med Assoc. 2020;70(5):815–9.
Singh NK, Sharma V, Trikha V, Gamanagatti S, Roy A, Balawat AS, et al. Is PFNA-II a better implant for stable intertrochanteric fractures in elderly population ? A prospective randomized study. J Clin Orthop Trauma. 2019;10(Suppl 1):71–s6.
Sharma A, Sethi A, Sharma S. Treatment of stable intertrochanteric fractures of the femur with proximal femoral nail versus dynamic hip screw: a comparative study. Rev Bras Ortop. 2018;53(4):477–81.
Bretherton CP, Parker MJ. Femoral medialization, fixation failures, and functional outcome in trochanteric hip fractures treated with either a sliding hip screw or an intramedullary nail from within a Randomized Trial. J Orthop Trauma. 2016;30(12):642–6.
Zhang C, Chen Z, Wang M, Chen W, Ding Z. Comparison of clinical outcomes with proximal femoral nail anti-rotation versus dynamic hip screw for unstable intertrochanteric femoral fractures: a meta-analysis. Med (Baltim). 2023;102(6):e32920.
Wessels JO, Bjarnesen MP, Erichsen JL, Palm H, Gundtoft PH, Viberg B. Sliding hip screw vs intramedullary nail for AO/OTA31A1-A3: a systematic review and meta-analysis. Injury. 2022;53(3):1149–59.
Xu H, Liu Y, Sezgin EA, Tarasevičius Å, Christensen R, Raina DB, et al. Comparative effectiveness research on proximal femoral nail versus dynamic hip screw in patients with trochanteric fractures: a systematic review and meta-analysis of randomized trials. J Orthop Surg Res. 2022;17(1):292.
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.
Tobias A. Assessing the influence of a single study in the meta-anyalysis estimate. STATA Tech Bull 1999, 8(47).
Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316(7129):469. author reply 70 – 1.
Saudan M, Lübbeke A, Sadowski C, Riand N, Stern R, Hoffmeyer P. Pertrochanteric fractures: is there an advantage to an intramedullary nail?: a randomized, prospective study of 206 patients comparing the dynamic hip screw and proximal femoral nail. J Orthop Trauma. 2002;16(6):386–93.
Xu YZ, Geng DC, Mao HQ, Zhu XS, Yang HL. A comparison of the proximal femoral nail antirotation device and dynamic hip screw in the treatment of unstable pertrochanteric fracture. J Int Med Res. 2010;38(4):1266–75.
Avakian Z, Shiraev T, Lam L, Hope N. Dynamic hip screws versus proximal femoral nails for intertrochanteric fractures. ANZ J Surg. 2012;82(1–2):56–9.
Luo F, Shen J, Xu J, Dong S, Huang Q, Xie Z. Treatment of AO/OTA 31-A3 intertrochanteric femoral fractures with a percutaneous compression plate. Clin (Sao Paulo). 2014;69(1):1–7.
Sevinç HF, Cirpar M, Canbeyli ID, Dağlar B, Oktas B, Durusoy S. Comparison of functional outcomes in patients fixed with dynamic hip screw and proximal femur nail-anti-rotation in A1 and A2 type intertrochanteric femur fractures. Ulus Travma Acil Cerrahi Derg. 2020;26(5):811–7.
Bastard C. [Femoral neck fracture]. Rev Prat. 2019;69(10):1124–8.
Shen L, Zhang Y, Shen Y, Cui Z. Antirotation proximal femoral nail versus dynamic hip screw for intertrochanteric fractures: a meta-analysis of randomized controlled studies. Orthop Traumatol Surg Res. 2013;99(4):377–83.
Matre K, Havelin LI, Gjertsen JE, Espehaug B, Fevang JM. Intramedullary nails result in more reoperations than sliding hip screws in two-part intertrochanteric fractures. Clin Orthop Relat Res. 2013;471(4):1379–86.
Parker MJ. Sliding hip screw versus intramedullary nail for trochanteric hip fractures; a randomised trial of 1000 patients with presentation of results related to fracture stability. Injury. 2017;48(12):2762–7.
Adams CI, Robinson CM, Court-Brown CM, McQueen MM. Prospective randomized controlled trial of an intramedullary nail versus dynamic screw and plate for intertrochanteric fractures of the femur. J Orthop Trauma. 2001;15(6):394–400.
Hoffman CW, Lynskey TG. Intertrochanteric fractures of the femur: a randomized prospective comparison of the Gamma nail and the Ambi hip screw. Aust N Z J Surg. 1996;66(3):151–5.
Leung KS, So WS, Shen WY, Hui PW. Gamma nails and dynamic hip screws for peritrochanteric fractures. A randomised prospective study in elderly patients. J Bone Joint Surg Br. 1992;74(3):345–51.
Park SR, Kang JS, Kim HS, Lee WH, Kim YH. Treatment of intertrochanteric fracture with the Gamma AP locking nail or by a compression hip screw–a randomised prospective trial. Int Orthop. 1998;22(3):157–60.
Selim A, Ponugoti N, Naqvi AZ, Magill H. Cephalo-medullary nailing versus dynamic hip screw with trochanteric stabilisation plate for the treatment of unstable per-trochanteric hip fractures: a meta-analysis. J Orthop Surg Res. 2021;16(1):47.
Ahrengart L, Törnkvist H, Fornander P, Thorngren KG, Pasanen L, Wahlström P et al. A randomized study of the compression hip screw and Gamma nail in 426 fractures. Clin Orthop Relat Res 2002(401):209–22.
Chua IT, Rajamoney GN, Kwek EB. Cephalomedullary nail versus sliding hip screw for unstable intertrochanteric fractures in elderly patients. J Orthop Surg (Hong Kong). 2013;21(3):308–12.
Yu W, Zhang X, Zhu X, Yu Z, Xu Y, Zha G, et al. Proximal femoral nails anti-rotation versus dynamic hip screws for treatment of stable intertrochanteric femur fractures: an outcome analyses with a minimum 4 years of follow-up. BMC Musculoskelet Disord. 2016;17:222.
Parker MJ, Handoll HH. Gamma and other cephalocondylic intramedullary nails versus extramedullary implants for extracapsular hip fractures. Cochrane Database Syst Rev 2004(1):Cd000093.
Bridle SH, Patel AD, Bircher M, Calvert PT. Fixation of intertrochanteric fractures of the femur. A randomised prospective comparison of the gamma nail and the dynamic hip screw. J Bone Joint Surg Br. 1991;73(2):330–4.
Barton TM, Gleeson R, Topliss C, Greenwood R, Harries WJ, Chesser TJ. A comparison of the long gamma nail with the sliding hip screw for the treatment of AO/OTA 31-A2 fractures of the proximal part of the femur: a prospective randomized trial. J Bone Joint Surg Am. 2010;92(4):792–8.
Hardy DC, Descamps PY, Krallis P, Fabeck L, Smets P, Bertens CL, et al. Use of an intramedullary hip-screw compared with a compression hip-screw with a plate for intertrochanteric femoral fractures. A prospective, randomized study of one hundred patients. J Bone Joint Surg Am. 1998;80(5):618–30.
Butt MS, Krikler SJ, Nafie S, Ali MS. Comparison of dynamic hip screw and gamma nail: a prospective, randomized, controlled trial. Injury. 1995;26(9):615–8.
Utrilla AL, Reig JS, Muñoz FM, Tufanisco CB. Trochanteric gamma nail and compression hip screw for trochanteric fractures: a randomized, prospective, comparative study in 210 elderly patients with a new design of the gamma nail. J Orthop Trauma. 2005;19(4):229–33.
Aktselis I, Kokoroghiannis C, Fragkomichalos E, Koundis G, Deligeorgis A, Daskalakis E, et al. Prospective randomised controlled trial of an intramedullary nail versus a sliding hip screw for intertrochanteric fractures of the femur. Int Orthop. 2014;38(1):155–61.
Pajarinen J, Lindahl J, Michelsson O, Savolainen V, Hirvensalo E. Pertrochanteric femoral fractures treated with a dynamic hip screw or a proximal femoral nail. A randomised study comparing post-operative rehabilitation. J Bone Joint Surg Br. 2005;87(1):76–81.
Papasimos S, Koutsojannis CM, Panagopoulos A, Megas P, Lambiris E. A randomised comparison of AMBI, TGN and PFN for treatment of unstable trochanteric fractures. Arch Orthop Trauma Surg. 2005;125(7):462–8.
Schemitsch EH, Nowak LL, Schulz AP, Brink O, Poolman RW, Mehta S, et al. Intramedullary Nailing vs sliding hip screw in Trochanteric Fracture Management: the INSITE Randomized Clinical Trial. JAMA Netw Open. 2023;6(6):e2317164.
Reindl R, Harvey EJ, Berry GK, Rahme E. Intramedullary Versus Extramedullary fixation for unstable intertrochanteric fractures: a prospective Randomized Controlled Trial. J Bone Joint Surg Am. 2015;97(23):1905–12.
Harrington P, Nihal A, Singhania AK, Howell FR. Intramedullary hip screw versus sliding hip screw for unstable intertrochanteric femoral fractures in the elderly. Injury. 2002;33(1):23–8.
Little NJ, Verma V, Fernando C, Elliott DS, Khaleel A. A prospective trial comparing the Holland nail with the dynamic hip screw in the treatment of intertrochanteric fractures of the hip. J Bone Joint Surg Br. 2008;90(8):1073–8.
Parker MJ, Bowers TR, Pryor GA. Sliding hip screw versus the Targon PF nail in the treatment of trochanteric fractures of the hip: a randomised trial of 600 fractures. J Bone Joint Surg Br. 2012;94(3):391–7.
Parker MJ, Cawley S. Sliding hip screw versus the Targon PFT nail for trochanteric hip fractures: a randomised trial of 400 patients. Bone Joint J 2017, 99–b(9):1210–5.
Matre K, Vinje T, Havelin LI, Gjertsen JE, Furnes O, Espehaug B, et al. TRIGEN INTERTAN intramedullary nail versus sliding hip screw: a prospective, randomized multicenter study on pain, function, and complications in 684 patients with an intertrochanteric or subtrochanteric fracture and one year of follow-up. J Bone Joint Surg Am. 2013;95(3):200–8.
Sanders D, Bryant D, Tieszer C, Lawendy AR, MacLeod M, Papp S, et al. A Multicenter Randomized Control Trial comparing a Novel Intramedullary device (InterTAN) Versus Conventional Treatment (sliding hip screw) of geriatric hip fractures. J Orthop Trauma. 2017;31(1):1–8.
Huang SG, Chen B, Zhang Y, Nie FF, Ju L, Li M, et al. Comparison of the clinical effectiveness of PFNA, PFLCP, and DHS in treatment of unstable intertrochanteric femoral fracture. Am J Ther. 2017;24(6):e659–e66.
Zehir S, Zehir R, Zehir S, Azboy İ, Haykir N. Proximal femoral nail antirotation against dynamic hip screw for unstable trochanteric fractures; a prospective randomized comparison. Eur J Trauma Emerg Surg. 2015;41(4):393–400.
Zou J, Xu Y, Yang H. A comparison of proximal femoral nail antirotation and dynamic hip screw devices in trochanteric fractures. J Int Med Res. 2009;37(4):1057–64.
Acknowledgements
Not applicable.
Funding
Guangzhou Science and Technology Plan Project (202201011757); Guangdong Provincial University Characteristic Innovation Project (2018WTSCX083); Guangdong Education Science 13th Five-year Plan University Philosophy and Social Science Special Research Project (2019GXJK094).
Author information
Authors and Affiliations
Contributions
F Y contributed to selection of articles and statistical analysis. YW T, and J W contributed to quality assessment. ZC L contributed to statistical analysis of present study. YBL contributed substantially to the acquisition of data and drafted the article. All authors contributed to the writing and critical revisions for intellectual content and final approval of the article.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Yu, F., Tang, YW., Wang, J. et al. Does intramedullary nail have advantages over dynamic hip screw for the treatment of AO/OTA31A1-A3? A meta-analysis. BMC Musculoskelet Disord 24, 588 (2023). https://doi.org/10.1186/s12891-023-06715-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12891-023-06715-0